Stock PHXM PHAXIAM THERAPEUTICS S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart PHAXIAM Therapeutics S.A.

Equities

PHXM

FR001400K4B1

End-of-day quote Euronext Paris
Other stock markets
 06:00:00 2024-05-26 pm EDT 		5-day change 1st Jan Change
3.03 EUR 0.00% Intraday chart for PHAXIAM Therapeutics S.A. -0.33% -34.13%
Apr. 15 Phaxiam initiates trial in infective endocarditis CF
Apr. 15 PHAXIAM Therapeutics Announces Enrolment of First Patient in the Phase 1 Study for the Treatment of Endocarditis Infections Caused by Staphylococcus Aureus CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
PHAXIAM THERAPEUTICS S.A.
Bio Therapeutic Drugs
0.00%-0.33%-34.13%-67.17%-95.30% 20.09M
Bullish
Bearish
Bearish

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. PHXM Stock
  4. Charts PHAXIAM Therapeutics S.A.
  5. Comparison Chart